aki - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced renal perfusion leads to decreased glomerular filtration rate (GFR), often due to hypovolemia or heart failure, impairing the kidneys' ability to filter waste and balance fluids and electrolytes.

• Secondary mechanism: Tubular injury, especially acute tubular necrosis, results from ischemia or toxins, causing cell death and further reducing nephron function, which exacerbates the decline in GFR.

• Key complication: Electrolyte imbalances, particularly hyperkalemia, can arise from impaired excretion, posing risks of cardiac arrhythmias and necessitating careful monitoring and management.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Kidney Disease Stage 2

• Current medications: Lisinopril, Metformin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and fatigue

• Key symptoms: Swelling in legs, nausea, shortness of breath

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 94% on room air

Section 1

As the healthcare team conducts an initial assessment, the patient's condition reveals further concerning details. The physical examination highlights significant bilateral pitting edema in the lower extremities, suggesting volume overload. Lung auscultation reveals fine crackles at the bases, indicating possible pulmonary congestion. Despite a relatively stable oxygen saturation of 94% on room air, the patient's respiratory rate remains elevated at 22 breaths per minute, and he reports increased shortness of breath, particularly when lying flat. These respiratory signs raise the suspicion of heart failure exacerbation contributing to the acute kidney injury (AKI).

Laboratory results paint a clearer picture of the underlying complications. The patient's serum potassium level is 5.8 mEq/L, indicating hyperkalemia, a common complication in AKI that requires prompt intervention to prevent cardiac arrhythmias. Blood urea nitrogen (BUN) and creatinine levels are elevated at 45 mg/dL and 2.8 mg/dL, respectively, confirming the decline in renal function. The estimated glomerular filtration rate (eGFR) has decreased significantly from baseline, aligning with the clinical presentation of decreased urine output and fluid retention.

These findings necessitate a reevaluation of the treatment plan, focusing on addressing the potential volume overload and electrolyte imbalances. The healthcare team considers adjusting diuretic therapy to alleviate fluid retention while carefully monitoring renal function and electrolytes. Collaborative discussions emphasize the importance of balancing interventions to prevent further nephron injury and stabilize the patient's cardiac status. As the team deliberates on the next steps, they remain vigilant for any signs of life-threatening complications, such as severe hyperkalemia or worsening pulmonary edema, which would require immediate intervention.

Section 2

New complications arise as the healthcare team continues to monitor the patient's condition closely. Despite initial interventions, the patient develops worsening pulmonary edema, evidenced by an increase in respiratory distress and hypoxemia. The oxygen saturation has decreased to 90% on room air, prompting the need for supplemental oxygen therapy. The patient reports an inability to lie flat due to severe orthopnea, and the presence of coarse crackles has now extended to the mid-lung fields upon auscultation. The escalation of respiratory symptoms suggests an urgent need to reassess the fluid management strategy and consider the potential initiation of non-invasive positive pressure ventilation to improve gas exchange.

In parallel, the patient's hyperkalemia remains a pressing concern. Repeat laboratory tests show a serum potassium level rising to 6.2 mEq/L. The risk of cardiac arrhythmias is heightened, necessitating immediate medical intervention. The healthcare team swiftly administers calcium gluconate to stabilize the cardiac membrane, along with insulin and glucose to drive potassium back into the cells. Additionally, sodium polystyrene sulfonate is prescribed to facilitate potassium excretion through the gastrointestinal tract. While these measures are implemented, continuous cardiac monitoring is essential, as the patient is now at increased risk for life-threatening arrhythmias.

As the patient’s clinical status evolves, the team must evaluate the effectiveness of these interventions and remain prepared to escalate care if needed. Considering the complexity of managing both fluid overload and electrolyte imbalances, the interdisciplinary team discusses the potential need for renal replacement therapy should the patient’s renal function fail to improve. This decision hinges on a delicate balance of maintaining hemodynamic stability while preventing further renal compromise. The healthcare team remains vigilant, ready to adapt the treatment plan as the patient's condition unfolds, with a concerted focus on mitigating complications and preventing further deterioration.

Section 3

As the healthcare team continues to monitor the patient, new diagnostic results reveal further insights into the evolving condition. A chest X-ray is performed, showing bilateral pulmonary infiltrates consistent with worsening pulmonary edema. Additionally, an echocardiogram suggests a reduced ejection fraction, raising concerns about underlying cardiac dysfunction contributing to the patient's fluid overload. This finding necessitates a re-evaluation of the current treatment plan, particularly the management of the patient’s fluid status and cardiac support. The patient's lab work also indicates a declining glomerular filtration rate (GFR), now at 18 mL/min/1.73m², suggesting a progression towards severe acute kidney injury.

In light of these developments, the healthcare team intensifies their focus on optimizing the patient's cardiac and renal function. A cardiology consult is requested to further assess the potential cardiac etiology of the pulmonary symptoms and to recommend appropriate pharmacologic interventions, such as the initiation of diuretics with caution due to the renal impairment. The nephrology team is consulted to discuss the feasibility and timing of initiating renal replacement therapy, especially given the patient's deteriorating renal function and persistent electrolyte imbalances.

As the team synthesizes these new diagnostic results, they recognize the need for a collaborative and dynamic approach to the patient's care. The recent findings underscore the importance of balancing fluid removal to alleviate pulmonary congestion while considering the risks of exacerbating renal damage. This delicate balance requires close monitoring of vital signs, continuous assessment of the patient's respiratory status, and frequent laboratory evaluations to guide ongoing treatment decisions. With these considerations in mind, the team prepares to adjust the therapeutic strategy to stabilize the patient and prevent further complications, while remaining vigilant to any signs of rapid deterioration.

Section 4

As the healthcare team proceeds with the adjusted treatment plan, they closely monitor the patient's response to the interventions. Despite cautious administration of diuretics to address the pulmonary edema, the patient exhibits a notable change in status. Within 24 hours, there is a significant shift in vital signs: the patient's blood pressure has dropped to 88/54 mmHg, and the heart rate has increased to 115 beats per minute, indicating a possible hypovolemic state or worsening cardiac output. Oxygen saturation levels remain borderline at 91% on high-flow oxygen, suggesting persistent respiratory compromise. The patient also reports increased shortness of breath and a feeling of fatigue, raising concerns about the adequacy of the current therapeutic approach.

Lab results from the most recent tests reveal further electrolyte imbalances, with serum potassium rising to 5.8 mmol/L and creatinine levels climbing to 3.9 mg/dL, indicative of continued renal dysfunction. The decline in renal function is coupled with metabolic acidosis, as evidenced by a decreased serum bicarbonate level of 17 mmol/L. These findings necessitate a re-evaluation of the diuretic therapy and the potential need for initiating renal replacement therapy. Meanwhile, the cardiology team, after reviewing the echocardiogram, recommends the cautious use of inotropic support to enhance cardiac output, taking into account the patient's compromised renal status and the risk of exacerbating the fluid imbalance.

Faced with these developments, the healthcare team gathers to refine the care plan. The priority is to stabilize hemodynamics while balancing fluid removal and preserving renal function. Continuous hemodynamic monitoring and frequent arterial blood gas analysis are initiated to guide titration of medications and adjustments in fluid management. The team also emphasizes the need for vigilant monitoring for any signs of arrhythmias or further hemodynamic instability, given the electrolyte disturbances and cardiac stress. This integrated approach aims to stabilize the patient and prevent the progression of complications, while setting the stage for the next critical steps in the patient's treatment journey.

Section 5

As the healthcare team implements the refined care plan, they diligently monitor the patient's response to the interventions. Within 12 hours, there is a noticeable change in the patient's clinical status. The patient becomes increasingly lethargic, and their mental status shifts to confusion, suggesting possible cerebral hypoperfusion or worsening metabolic imbalance. Vital signs reveal further deterioration: blood pressure has decreased to 82/50 mmHg, heart rate remains elevated at 120 beats per minute, and oxygen saturation has dropped to 89% despite continuous high-flow oxygen support. These signs raise concern about the patient's ability to maintain adequate perfusion and oxygenation under the current treatment regimen.

New diagnostic results from arterial blood gas analysis show a worsening metabolic acidosis, with a pH of 7.28 and bicarbonate level now at 15 mmol/L. Additionally, serum potassium has increased further to 6.2 mmol/L, heightening the risk of potentially life-threatening arrhythmias. The decision is made to initiate continuous renal replacement therapy (CRRT) to address both the volume overload and severe electrolyte imbalances, while cautious inotropic support is continued to enhance cardiac output. The nursing staff is instructed to initiate frequent neuro checks and maintain cardiac monitoring to promptly detect any arrhythmic events.

As the CRRT begins, the patient's hemodynamic parameters show initial signs of stabilization, with slight improvements in blood pressure and oxygenation levels. The clinical team remains vigilant, aware that the patient's condition is precarious and that any new complications, such as infection or further cardiac compromise, could significantly impact the recovery trajectory. The focus remains on maintaining hemodynamic stability, correcting metabolic imbalances, and closely observing the patient's response to this critical intervention, setting the stage for potential improvement in renal function and overall status.